Terry Vance

Insider Reports History

Location
Watertown, MA
Signature
/s/ Matthew Kowalsky as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Terry Vance:

Company Role Class Num Shares Value Price $ Report Date Ownership
ENANTA PHARMACEUTICALS INC Director Stock Option (right to buy) 15,700 13 Mar 2025 Direct

Insider Reports Filed by Terry Vance

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ENTA ENANTA PHARMACEUTICALS INC 13 Mar 2025 1 $0 4 Director 14 Mar 2025, 17:44
ENTA ENANTA PHARMACEUTICALS INC 06 Mar 2024 1 $0 4 Director 08 Mar 2024, 17:30
ENTA ENANTA PHARMACEUTICALS INC 13 Dec 2023 1 -$139,490 4 Director 15 Dec 2023, 20:08
ENTA ENANTA PHARMACEUTICALS INC 16 Mar 2023 2 +$81,200 4 Director 17 Mar 2023, 18:46
ENTA ENANTA PHARMACEUTICALS INC 02 Mar 2023 1 $0 4 Director 06 Mar 2023, 16:21
ENTA ENANTA PHARMACEUTICALS INC 03 Mar 2022 1 $0 4 Director 07 Mar 2022, 17:52